The First 50 Years of Molecular Pharmacology

Joan Heller Brown; William A Catterall; P Jeffrey Conn; Stuart G Cull-Candy; Ray Dingledine; T Kendall Harden; Paul A Insel; Graeme Milligan; Stephen F Traynelis

doi:10.1124/mol.115.099564

The First 50 Years of Molecular Pharmacology

Mol Pharmacol. 2015 Jul;88(1):139-40. doi: 10.1124/mol.115.099564. Epub 2015 May 5.

Authors

Joan Heller Brown¹, William A Catterall¹, P Jeffrey Conn¹, Stuart G Cull-Candy¹, Ray Dingledine¹, T Kendall Harden¹, Paul A Insel¹, Graeme Milligan¹, Stephen F Traynelis²

Affiliations

¹ Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.).
² Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.) strayne@emory.edu.

PMID: 25943115
DOI: 10.1124/mol.115.099564

Abstract

In this Perspective, former and current editors of Molecular Pharmacology, together with the guest editors for this 50th Anniversary Issue, provide a historical overview of the journal since its founding in 1965. The substantial impact that Molecular Pharmacology has had on the field of pharmacology as well as on biomedical science is discussed, as is the broad scope of the journal. The authors conclude that, true to the original goals for the journal, Molecular Pharmacology today remains an outstanding venue for work that provides a mechanistic understanding of drugs, molecular probes, and their biologic targets.

Publication types

Historical Article
Review

MeSH terms

Animals
Drug Delivery Systems
History, 20th Century
Humans
Periodicals as Topic / trends*
Pharmaceutical Preparations / chemistry
Pharmacogenetics / history*

Substances

Pharmaceutical Preparations